Literature DB >> 27778457

Comparison of Digital 12-Lead ECG and Digital 12-Lead Holter ECG Recordings in Healthy Male Subjects: Results from a Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.

Duolao Wang1, Ameet Bakhai2, Radivoj Arezina3, Jörg Täubel3.   

Abstract

BACKGROUND: Electrocardiogram (ECG) variability is greatly affected by the ECG recording method. This study aims to compare Holter and standard ECG recording methods in terms of central locations and variations of ECG data.
METHODS: We used the ECG data from a double-blinded, placebo-controlled, randomized clinical trial and used a mixed model approach to assess the agreement between two methods in central locations and variations of eight ECG parameters (Heart Rate, PR, QRS, QT, RR, QTcB, QTcF, and QTcI intervals).
RESULTS: A total of 34 heathy male subjects with mean age of 25.7 ± 4.78 years were randomized to receive either active drug or placebo. Digital 12-lead ECG and digital 12-lead Holter ECG recordings were performed to assess ECG variability. There are no significant differences in least square mean between the Holter and the standard method for all ECG parameters. The total variance is consistently higher for the Holter method than the standard method for all ECG parameters except for QRS. The intraclass correlation coefficient (ICC) values for the Holter method are consistently lower than those for the standard method for all ECG parameters except for QRS, in particular, the ICC for QTcF is reduced from 0.86 for the standard method to 0.67 for the Holter method.
CONCLUSIONS: This study suggests that Holter ECGs recorded in a controlled environment are not significantly different but more variable than those from the standard method.
© 2016 Wiley Periodicals, Inc.

Keywords:  Holter 12-lead ECG; cardiac safety; mixed model; standard 12-lead ECG

Mesh:

Substances:

Year:  2016        PMID: 27778457      PMCID: PMC6931472          DOI: 10.1111/anec.12363

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  15 in total

1.  Problems of heart rate correction in assessment of drug-induced QT interval prolongation.

Authors:  M Malik
Journal:  J Cardiovasc Electrophysiol       Date:  2001-04

2.  Agreement between methods of measurement with multiple observations per individual.

Authors:  J Martin Bland; Douglas G Altman
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

3.  Is a thorough QTc study necessary? The role of modeling and simulation in evaluating the QTc prolongation potential of drugs.

Authors:  Shashank Rohatagi; Timothy J Carrothers; Jon Kuwabara-Wagg; Tatiana Khariton
Journal:  J Clin Pharmacol       Date:  2009-09-04       Impact factor: 3.126

4.  Tolerability and pharmacokinetics of ACT-280778, a novel nondihydropyridine dual L/T-type calcium channel blocker: early clinical studies in healthy male subjects using adaptive designs.

Authors:  Markus S Mueller; Kasra Shakeri-Nejad; Marcelo M Gutierrez; Andreas Krause; Jörg Täubel; Brian Sanderson; Jasper Dingemanse
Journal:  J Cardiovasc Pharmacol       Date:  2014-02       Impact factor: 3.105

5.  Comparison of six commonly used QT correction models and their parameter estimation methods.

Authors:  Duolao Wang; Jorg Taubel; Radivoj Arezina
Journal:  J Biopharm Stat       Date:  2012       Impact factor: 1.051

Review 6.  Early investigation of QTc liability: the role of multiple ascending dose (MAD) study.

Authors:  Rashmi R Shah; Joel Morganroth
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

7.  Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rate.

Authors:  C P Lau; A R Freedman; S Fleming; M Malik; A J Camm; D E Ward
Journal:  Cardiovasc Res       Date:  1988-01       Impact factor: 10.787

8.  Autonomic nervous system influences on QT interval in normal subjects.

Authors:  Anthony R Magnano; Steve Holleran; Rajasekhar Ramakrishnan; James A Reiffel; Daniel M Bloomfield
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

9.  Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects.

Authors:  Jorg Taubel; Georg Ferber; Ulrike Lorch; Velislav Batchvarov; Irina Savelieva; A John Camm
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

10.  Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.

Authors:  Nenad Sarapa; Joel Morganroth; Jean-Philippe Couderc; Steven F Francom; Borje Darpo; Joseph C Fleishaker; Janet D McEnroe; William T Chen; Wojciech Zareba; Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

View more
  3 in total

1.  Effect of Mobile Internet on Attitude and Self-Efficacy of Patients with Coronary Heart Disease Diagnosed by 12-Lead Holter ECG.

Authors:  Haitao Sun; Jing Li; Yue Wang; Xiaoke Ma
Journal:  J Healthc Eng       Date:  2022-01-07       Impact factor: 2.682

2.  Current Use and Future Needs of Noninvasive Ambulatory Electrocardiogram Monitoring.

Authors:  Takanori Ikeda
Journal:  Intern Med       Date:  2020-08-12       Impact factor: 1.271

3.  Comparing the consistency of electrocardiogram interval measurements by resting ECG versus 12-lead Holter.

Authors:  Boaz Mendzelevski; Christopher S Spencer; Anne Freier; Dorothée Camilleri; Claus Graff; Jörg Täubel
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-05-04       Impact factor: 1.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.